AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2022
Dec 30, 2022
35599_dirs_2022-12-30_7214088b-5d0e-4110-9635-8bcea404da9e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2022-12-28
Reporting Person: Andrade Robert (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-28 | Common shares | S | 11000 | $9.6145 | Disposed | 160721 | Direct |
| 2022-12-29 | Common shares | S | 5500 | $9.5748 | Disposed | 155221 | Direct |
| 2022-12-30 | Common shares | S | 5500 | $9.6122 | Disposed | 149721 | Direct |
Footnotes
F1: Represents shares sold pursuant to a 10b5-1 plan on December 28, 2022.
F2: Represents shares sold pursuant to a 10b5-1 plan on December 29, 2022.
F3: Represents shares sold pursuant to a 10b5-1 plan on December 30, 2022.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20